Thus, the expression pattern of ZP2 in tumor cells may provide an opportunity for the detection of circulating or disseminated tumor cells in body fluids, and, in principle, for an early diagnosis of cancer via a negative selection mode strategy [25,26]. This evidence concerns the gene ZP2 and cancer.